drugset
drugset / Trial / NCT04446897

Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction

NCT04446897 ↗

Phase 1/2 Completed 10 enrolled Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus Belarusian Medical Academy of Post-Graduate Education · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Treatment of chronic medium-severe periodontitis with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction

Timeline

Start
2020-08-03
Primary completion
2020-12-31
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy — —

Indications

chronic periodontitis